Press Releases

Junshi Biosciences , a China-based biopharmaceutical company specializing in discovery, development and commercialization of novel therapies, and Merck, a world leading science and technology company, announced their collaboration on a clinical trial program designed to investigate the efficacy and...

Eli Lilly and Company announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19. This investigational medicine, referred to as LY-CoV555, is the first to emerge from the collaboration between Lilly...

Honeywell announced Fast Track Automation, a combination of proprietary technology innovations for the life sciences industry that enables vital vaccines, treatments and therapies to move from regulatory approval to full production in as little as two months depending on...

Takeda Pharmaceutical Company Limited announced the results of the Phase 2 Pevonedistat-2001 trial will be presented during oral sessions at the virtual 56th American Society of Clinical Oncology (ASCO) Annual Meeting and the virtual 25th European Hematology Association (EHA)...

There are two abnormal proteins associated with Alzheimer’s disease. The first is amyloid. The second is tau. Eli Lilly announced that the U.S. FDA approved its Tauvid, a radioactive diagnostic agent for PET imaging in Alzheimer’s patients. It is...

MedPharm Ltd, a world-leading contract developer of topical and transdermal pharmaceutical products, has taken the first steps to expand its manufacturing capacity in the US to complement an existing manufacturing facility in the UK. MedPharm has obtained a facility...

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as...